{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:22:49Z","timestamp":1783606969737,"version":"3.55.0"},"reference-count":44,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                    <jats:p\/>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Multigene panel testing (MGPT) has increased the detection of SDHA pathogenic\/likely pathogenic (P\/LP) variants in cancer patients, but their clinical interpretation remains challenging due to low penetrance and lack of gene-specific variant interpretation guidelines. This study aimed to evaluate the prevalence and clinical relevance of germline and somatic SDHA P\/LP variants in cancer patients. A total of 1,699 consecutively referred cancer patients underwent MGPT between 2021 and 2023. Population controls were obtained from the gnomAD database. When available, tumour samples were analysed for RNA-level characterisation and SDHA loss of heterozygosity (LOH). In addition, SDHA copy number variations (CNVs) were assessed in 10,463 pan-cancer and 8,037 breast tumour samples in silico. Germline SDHA variants were rare: 19 heterozygous variants (8 P\/LP and 11 variants of unknown significance (VUS)) were identified. No association between SDHA variants and tumour types was observed, and LOH was absent in non-SDHA-associated tumours. AI-based functional predictions suggested potential pathogenicity for a subset of VUS, but their role remained uncertain. Somatic SDHA deletions were detected in 2.5% of pan-cancer and 5.4% of breast tumour samples. In breast cancer, SDHA CNV loss was associated with significantly worse overall and relapse-free survival (HR = 1.55 and 1.48, respectively; P &amp;lt; 0.05). However, CNVs extended across a 375 kb region around the SDHA locus, suggesting that this association may be related to 5p chromosomal deletions rather than the SDHA loss alone. In conclusion, germline SDHA variants are rare and likely incidental in most cancers, but somatic 5p chromosomal deletions, including SDHA in breast cancer, may have a prognostic value.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/erc-25-0281","type":"journal-article","created":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T16:13:02Z","timestamp":1770048782000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of germline and somatic\n                    <i>SDHA<\/i>\n                    alterations reveals rare incidental germline variants and prognostic implications of somatic loss in breast cancer"],"prefix":"10.1530","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1664-409X","authenticated-orcid":true,"given":"Henriett","family":"Butz","sequence":"first","affiliation":[{"name":"1"},{"name":"2"},{"name":"3"},{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1lint","family":"Antal","sequence":"additional","affiliation":[{"name":"2"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1nos","family":"Papp","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anik\u00f3","family":"Bozsik","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vince Korn\u00e9l","family":"Grolmusz","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Nagy","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T\u00edmea","family":"P\u00f3cza","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Sanceau","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8190-5853","authenticated-orcid":true,"given":"Judith","family":"Favier","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7506-674X","authenticated-orcid":true,"given":"Attila","family":"Pat\u00f3cs","sequence":"additional","affiliation":[{"name":"1"},{"name":"2"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2026,2,2]]},"reference":[{"key":"2026070909461845500_bib1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"2026070909461845500_bib2","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1038\/s41436-019-0586-y","article-title":"Addendum: a practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"21","author":"Bashford","year":"2019","journal-title":"Genet Med"},{"key":"2026070909461845500_bib3","doi-asserted-by":"crossref","first-page":"T65","DOI":"10.1530\/ERC-19-0454","article-title":"Hereditary endocrine tumours: current state-of-the-art and research opportunities: challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes","volume":"27","author":"Brock","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"2026070909461845500_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036541","article-title":"Cancer genetic counseling \u2013 current practice and future challenges","volume":"10","author":"Schienda","year":"2020","journal-title":"Cold Spring Harb Perspect Med"},{"key":"2026070909461845500_bib5","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14737159.2017.1267567","article-title":"Care delivery considerations for widespread and equitable implementation of inherited cancer predisposition testing","volume":"17","author":"Cragun","year":"2017","journal-title":"Expert Rev Mol Diagn"},{"key":"2026070909461845500_bib6","article-title":"Cost-effectiveness of genetic testing of endocrine tumor patients using a comprehensive hereditary cancer gene panel","volume":"3","author":"Pat\u00f3cs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909461845500_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41436-021-01171-4","article-title":"Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2021 update: a policy statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Miller","year":"2021","journal-title":"Genet Med"},{"key":"2026070909461845500_bib8","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"2026070909461845500_bib9","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","author":"Burnichon","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2026070909461845500_bib10","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/sj.onc.1209594","article-title":"Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer","volume":"25","author":"King","year":"2006","journal-title":"Oncogene"},{"key":"2026070909461845500_bib11","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","article-title":"TET-mediated hypermethylation primes SDH-deficient cells for HIF2\u03b1-Driven mesenchymal transition","volume":"30","author":"Morin","year":"2020","journal-title":"Cell Rep"},{"key":"2026070909461845500_bib12","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jmedgenet-2021-108355","article-title":"UK recommendations for SDHA germline genetic testing and surveillance in clinical practice","volume":"60","author":"Hanson","year":"2023","journal-title":"J Med Genet"},{"key":"2026070909461845500_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1210\/jc.2017-01762","article-title":"Clinical aspects of SDHA-related pheochromocytoma and paraganglioma: a nationwide study","volume":"103","author":"van der Tuin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909461845500_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/2193-1801-2-299","article-title":"Succinate dehydrogenase expression in breast cancer","volume":"2","author":"Kim","year":"2013","journal-title":"Springerplus"},{"key":"2026070909461845500_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.adg7492","article-title":"Accurate proteome-wide missense variant effect prediction with AlphaMissense","volume":"381","author":"Cheng","year":"2023","journal-title":"Science"},{"key":"2026070909461845500_bib16","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","author":"Korpershoek","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909461845500_bib17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1001\/jamaoncol.2022.4071","article-title":"Differences in cancer phenotypes among frequent CHEK2 variants and implications for clinical care \u2013 checking CHEK2","volume":"8","author":"Bychkovsky","year":"2022","journal-title":"JAMA Oncol"},{"key":"2026070909461845500_bib18","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41436-020-0783-8","article-title":"Points to consider for reporting of germline variation in patients undergoing tumor testing: a statement of the American College of Medical Genetics and Genomics (ACMG)","volume":"22","author":"Li","year":"2020","journal-title":"Genet Med"},{"key":"2026070909461845500_bib19","article-title":"Germline testing data validate inferences of mutational status for variants detected from tumor-only sequencing","volume":"5","author":"Jalloul","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"2026070909461845500_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.13070","article-title":"Prevalence of germline findings among tumors from cancer types lacking hereditary testing guidelines","volume":"5","author":"Yap","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2026070909461845500_bib21","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.annonc.2022.12.003","article-title":"Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO precision medicine working group recommendations","volume":"34","author":"Kuzbari","year":"2023","journal-title":"Ann Oncol"},{"key":"2026070909461845500_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41481-y","article-title":"Challenging interpretation of germline TP53 variants based on the experience of a national comprehensive cancer centre","volume":"13","author":"Butz","year":"2023","journal-title":"Sci Rep"},{"key":"2026070909461845500_bib23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajhg.2021.03.010","article-title":"Machine learning-based reclassification of germline variants of unknown significance: the RENOVO algorithm","volume":"108","author":"Favalli","year":"2021","journal-title":"Am J Hum Genet"},{"key":"2026070909461845500_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejca.2018.10.007","article-title":"Genetic counselling and testing of susceptibility genes for therapeutic decision-making in breast cancer \u2013 an European consensus statement and expert recommendations","volume":"106","author":"Singer","year":"2019","journal-title":"Eur J Cancer"},{"key":"2026070909461845500_bib25","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMra1806651","article-title":"Pheochromocytoma and paraganglioma","volume":"381","author":"Neumann","year":"2019","journal-title":"N Engl J Med"},{"key":"2026070909461845500_bib26","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41574-024-01024-5","article-title":"International consensus statement on the diagnosis and management of phaeochromocytoma and paraganglioma in children and adolescents","volume":"20","author":"Casey","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"2026070909461845500_bib27","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.1210\/jc.2013-1319","article-title":"A comprehensive next generation sequencing\u2013based genetic testing strategy to improve diagnosis of inherited pheochromocytoma and paraganglioma","volume":"98","author":"Rattenberry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909461845500_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jmedgenet-2015-103218","article-title":"Recommendations for somatic and germline genetic testing of single pheochromocytoma and paraganglioma based on findings from a series of 329 patients","volume":"52","author":"Curr\u00e1s-Freixes","year":"2015","journal-title":"J Med Genet"},{"key":"2026070909461845500_bib29","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.3390\/cancers13164219","article-title":"Analytical performance of NGS-based molecular genetic tests used in the diagnostic workflow of pheochromocytoma\/paraganglioma","volume":"13","author":"Sarkadi","year":"2021","journal-title":"Cancers"},{"key":"2026070909461845500_bib30","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/PAS.0000000000000149","article-title":"Succinate dehydrogenase deficiency is rare in pituitary adenomas","volume":"38","author":"Gill","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"2026070909461845500_bib31","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/cen.14289","article-title":"A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: beyond phaeochromocytoma and paraganglioma","volume":"93","author":"MacFarlane","year":"2020","journal-title":"Clin Endocrinol"},{"key":"2026070909461845500_bib32","article-title":"SDHA secondary findings in germline testing: counseling and surveillance considerations","volume":"4","author":"Skefos","year":"2024","journal-title":"Endocr Oncol"},{"key":"2026070909461845500_bib33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"2026070909461845500_bib34","article-title":"Combined germline and mosaic SDHA mutation is associated with a multicancer syndrome including neuroblastoma, renal cancer, and multifocal GI tumor","volume":"8","author":"Cranmer","year":"2024","journal-title":"JCO Precis Oncol"},{"key":"2026070909461845500_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13073-021-01004-8","article-title":"ClinGen variant curation interface: a variant classification platform for the application of evidence criteria from ACMG\/AMP guidelines","volume":"14","author":"Preston","year":"2022","journal-title":"Genome Med"},{"key":"2026070909461845500_bib36","article-title":"SDHA-related phaeochromocytoma and paraganglioma: review and clinical management","volume":"31","author":"Kaplan","year":"2024","journal-title":"Endocr Relat Cancer"},{"key":"2026070909461845500_bib37","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/modpathol.2015.41","article-title":"SDHB\/SDHA immunohistochemistry in pheochromocytomas and paragangliomas: a multicenter interobserver variation analysis using virtual microscopy: a multinational study of the European Network for the Study of Adrenal Tumors (ENS@T)","volume":"28","author":"Papathomas","year":"2015","journal-title":"Mod Pathol"},{"key":"2026070909461845500_bib38","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1210\/clinem\/dgae797","article-title":"Biomarkers improving genetic and metastatic disease prediction in paraganglioma: insights from a prospective study","volume":"110","author":"Drossart","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909461845500_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.750","article-title":"Copy number alterations associated with clinical features in an underrepresented population with breast cancer","volume":"7","author":"Rodrigues-Peres","year":"2019","journal-title":"Mol Genet Genomic Med"},{"key":"2026070909461845500_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51480","article-title":"Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing","volume":"9","author":"Baslan","year":"2020","journal-title":"Elife"},{"key":"2026070909461845500_bib41","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.molmed.2024.04.017","article-title":"Copy number alterations: a catastrophic orchestration of the breast cancer genome","volume":"30","author":"Shahrouzi","year":"2024","journal-title":"Trends Mol Med"},{"key":"2026070909461845500_bib42","doi-asserted-by":"crossref","DOI":"10.1101\/mcs.a002584","article-title":"Germline SDHA mutations in children and adults with cancer","volume":"4","author":"Dubard Gault","year":"2018","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"2026070909461845500_bib43","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","article-title":"Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer","volume":"81","author":"Evans","year":"2021","journal-title":"Cancer Res"},{"key":"2026070909461845500_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101534","article-title":"Energy metabolism pathways in breast cancer progression: the reprogramming, crosstalk, and potential therapeutic targets","volume":"26","author":"Zheng","year":"2022","journal-title":"Transl Oncol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/33\/2\/ERC-25-0281.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/33\/2\/ERC-25-0281.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0281\/506126\/erc-25-0281.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0281\/506126\/erc-25-0281.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:46:27Z","timestamp":1783604787000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/33\/2\/e250281\/75585\/Comprehensive-analysis-of-germline-and-somatic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0281","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,1]]},"article-number":"e250281"}}